Clinical Trial Update: Innovative Sternal Closure Techniques: Evaluating STRATAFIX™ and DERMABOND™ for Reduced Complications in CABG Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating STRATAFIX and DERMABOND for reducing complications after coronary artery bypass grafting; status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Mediastinitis
• Superficial Sternal Wound Infection
• Surgical Site Infection

Drugs mentioned

• Dermabond (2-octyl cyanoacrylate)
• Stratafix

Snippet

Sponsor: Unity Health Toronto | Conditions: Cardiovascular Disease, Surgical Site Infection | Phase 4 | Status: NOT_YET_RECRUITING